Přehled o publikaci
2023
Twenty-five years of epilepsy surgery at a Central European comprehensive epilepsy center-Trends in intervention delay and outcomes
VŠIANSKÝ, Vít, Milan BRÁZDIL, Ivan REKTOR, Irena DOLEŽALOVÁ, Jitka KOČVAROVÁ et. al.Basic information
Original name
Twenty-five years of epilepsy surgery at a Central European comprehensive epilepsy center-Trends in intervention delay and outcomes
Authors
VŠIANSKÝ, Vít, Milan BRÁZDIL, Ivan REKTOR, Irena DOLEŽALOVÁ, Jitka KOČVAROVÁ, Ondřej STRÝČEK, Jan HEMZA, Jan CHRASTINA, Eva BRICHTOVÁ, Ondřej HORÁK, Patrícia MUŽLAYOVÁ, Markéta HERMANOVÁ, Michal HENDRYCH and Martin PAIL
Edition
Epilepsia Open, HOBOKEN, WILEY, 2023, 2470-9239
Other information
Language
English
Type of outcome
Article in a journal
Country of publisher
United States of America
Confidentiality degree
is not subject to a state or trade secret
References:
Organization
Lékařská fakulta – Repository – Repository
UT WoS
001004555400001
Keywords in English
drug-resistant epilepsy; drug-resistant epilepsy epidemiology; drug-resistant epilepsy surgery
Links
LX22NPO5107, research and development project.
Changed: 24/1/2024 03:13, RNDr. Daniel Jakubík
Abstract
V originále
lt; 0.001). For resections, better outcomes (ILAE scores 1a-2) have been achieved in extratemporal lesional (0%-21%-61%, P = 0.01, at least 2-year follow-up) patients. In temporal lesional patients, outcomes remained unchanged (at least 77% success rate). A longer duration of epilepsy predicted a less favorable outcome for resective procedures (P = 0.024) in patients with disease duration of less than 25 years. SignificanceThe spectrum of epilepsy surgery is shifting toward nonlesional and extratemporal cases. While success rates of extratemporal resections at our center are getting better, the average duration of epilepsy before surgical intervention is still very long and is not improving. This underscores the need for stronger collaboration between epileptologists and outpatient neurologists to ensure prompt and effective treatment for patients with drug-resistant epilepsy.